Radiation Oncologist at University Hospital Zurich @Unispital_USZ | Professor at University of Zurich @UZH_ch | @ESTRO_RT President

USZ Zurich
Joined February 2018
🚀 Virtual Grand Round in Radiation Oncology Latest results of the EXTEND trial 🎤 Dr. Chad Tang Addition of MTD to SoC for Oligometastatic Solid Tumors: Primary Analysis of EXTEND 📅 2. June 2026, 17:00–17:30 CEST 💻 Join us virtually here: lnkd.in/eiPx5WhQ
4
9
47
2,776
Matthias Guckenberger retweeted
Following his 2024–2026 presidency, Matthias Guckenberger reflects on a tenure dedicated to “Strengthening #RadOnc and #ESTRO through Partnership and Innovation.” 🎥 Watch his recap of key outcomes for our stakeholders 👇@Mat_Guc
4
11
1,248
Matthias Guckenberger retweeted
What a beautiful message at the end of @Mat_Guc presidency at #ESTRO26 passing the torch to @BarbaraJereczek! See you at #ESTRO27 in Milano, 21-25th of May 2027.
3
33
83
3,211
Matthias Guckenberger retweeted
Dear @ESTRO_RT and @Mat_Guc , thank you for letting this crew help you close out another great year! We hope we gave everyone in attendance some food for thought and inspiration for the trip home. And to the Closing Team: mission accomplished. 💫🍾 See you in Milan next year! – at Stockholm, Sweden
5
33
1,666
Matthias Guckenberger retweeted
🎥 In this #ESTRO26 opening interview, Matthias Guckenberger, President of ESTRO, sets the tone for the days ahead in Stockholm. What does “Innovating Radiation Oncology, Together” really mean in practice? Find out in the video. #radonc @oncoalert @vjoncology @Mat_Guc
12
19
1,553
❓ What is the optimal duration of ADT if combined with EBRT for definitive treatment of prostate cancer Virtual Grand Rounds in Radiation Oncology 🎙 Speaker: Dr. @NicholasZaorsky 📅 February 4th, 5 - 5.30 pm CET 💻 Join us virtually here: 👇 usz.ch/en/events/virtual-gra…
7
37
3,212
Virtual Grand Rounds in Radiation Oncology 🥊 Battle of the Treatment Fields: Advancing Radiation Therapy for Leptomeningeal Metastasis 📅 Today Dr. Jonathan Yang 5pm - 5:30pm CEST Please join virtually here 👇 usz.ch/en/event/virtual-gran…
1
18
1,531
Matthias Guckenberger retweeted
ASTRO is deeply disturbed by the inaccurate, inappropriate, and irresponsible NBC News piece on IORT. We feel this story harms care for breast cancer patients & have strongly rebutted it through our Breast Cancer Resource Panel & a letter from ASTRO CEO, Vivek S Kavadi, MD to NBC News. Read each here: Breast Resource Panel Statement ow.ly/aicz50X9ty1 Letter to NBC News from Dr. Vivek S. Kavadi ow.ly/Hvy550X9txZ
2
51
5
130
23,187
Matthias Guckenberger retweeted
Important prediction modeling for patients with oligometastatic cancer based on distant metastases velocity (DMV). Great collaboration and proud to contribute our @Sunnybrook data. No doubt that #SBRT is critical to advancing outcomes for these patients. pubmed.ncbi.nlm.nih.gov/4087…
5
24
1,597
Matthias Guckenberger retweeted
Join us for #ESTRO26 in Stockholm!!!
4
15
1
77
4,020
Matthias Guckenberger retweeted
Great collaboration between MOMENTUM and Oligocare registries, presenting the preliminary outcomes (of 15 institutions) regarding liver SBRT using MRI or CT guided approach during #ESTRO2025 !
13
2
48
3,338
Matthias Guckenberger retweeted
🎥 Exclusive interview this morning at #ESTRO25: We spoke with ESTRO President Prof Matthias Guckenberger about the congress highlights, this year’s theme of partnership, and the future of radiation oncology. Don’t miss his insights ⬇️ #Radiotherapy #CancerResearch @Mat_Guc
1
6
21
1,663
Matthias Guckenberger retweeted
SBRT + 💊 in oligomets: 🧍‍♂️2294 pts | 🫁, breast, prostate, colorectal ⚠️Grade 3+ AEs: 1.5% ✅ SBRT Safe with systemic tx! #SBRT #OligoCare #ESTRO25 @EORTC @ESTRO_RT @CiroFranzese1
3
59
3
152
11,672
Matthias Guckenberger retweeted
Outstanding #ESTRO25 plenary talk from Uffer Pascal, an entrepreneur with stage 4 #lungcancer “What if radiation oncology was a start up” Highlights the 5’s: Collaborate Communicate Learn from every Customer Cost Efficiency Culture
5
12
35
2,253
Matthias Guckenberger retweeted
📢 🚨#lungcancer peeps. Please consider Prof Andrea Bezjak from @UofT for your next IASLC president! A very deserving candidate and a great representative for #radonc!!! @ldawsonmd #lcsm
1
22
1
67
4,798
Matthias Guckenberger retweeted
🎉We’re excited to announce that the first patient has been randomised in the SPRINT study! The patient was enrolled at Inselspital in Bern, under the supervision of PI Professor Hossein Hemmatazad. 👉 project.eortc.org/e2-radiate… #E2RADIatE #OligoCare @piet_ost @Mat_Guc
1
6
1
21
2,828
Matthias Guckenberger retweeted
🏅 Interview with Dirk Verellen, recipient of the Emmanuel van der Schueren Award at #ESTRO25: Don’t miss his award lecture in Vienna! 📆 Saturday 3 May | 14:15 - 14:40 CEST | Plenary Hall 👉 Full interview here: bit.ly/4ifJd75 #Radonc #OncologyInnovation #ESTROAwards
2
4
9
1,052
SANO trial: non-surgical approach & organ preservation in pts esophageal cancer and complete clinical response after neoadjuvant RCT Virtual Grand Rounds in Radiation Oncology usz.ch/en/events/virtual-gra… Wednesday May 7th 17:00 – 17:30 - Safe the date ! Berend van der Wilk
1
23
1
57
3,750
This Wednesday 👇
❓ Role of SBRT-only in hormone-sensitive oligometastatic prostate cancer ❓ Value of 6-months ADT added to SBRT ❓ Appropriate endpoints Virtual Grand Rounds in Radiation Oncology usz.ch/en/events/virtual-gra… Proudly presenting: @BarbaraJereczek Wed April 2nd 17:00 – 17:30 CET 👇
6
23
1,670